Gpc Biotech Ag: Premium Company Profile

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Databook
Pages	45
ISBN Number	not applicable
Product Code	DAT09408

Price

£265.00
approximately: $521 | €337

PRINT £265 ($521 | €337)

Order above formats by FAX

Summary

Introduction

GPC Biotech (GPC), founded in 1997, has a business model relied on two pillars, as a service provider for preclinical research and as a product company with its own development pipeline. Later, the company changed its focus by developing a platform of base technologies, LeadCode, through collaborations with pharmaceutical partners and through the support of its own drug development projects.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

GPC is a biopharmaceutical company focused on discovery, development and commercialization of new anticancer drugs, Cell Cycle Inhibitors and antibodies against MHC class II-positive tumor cells. It's most advanced product candidate satraplatin is currently in SPARC Phase III trial, for the treatment of hormone-refractory prostate cancer.

The company's second lead product candidate, 1D09C3, is in Phase I clinical trials and is a monoclonal antibody indicated for the treatment of relapsed/refractory B-cell lymphomas, such as Hodgkin's and non-Hodgkin's lymphomas and chronic lymphocytic leukemia.

The company's total revenues increased at a CAGR of 1.3% during 2002-2006, from $27.6 million to $29.1 million. This represents an absolute total growth of +$1.5 million during the historical period. The company's biggest contributor to revenue growth during 2002-2006 was license, collaboration and other revenues.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: GPC - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: GPC - Key Facts
- Table 2: GPC - Locations and Subsidiaries
- Table 3: GPC - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: GPC - Key Events Impacting Share Price Performance
- Table 5: GPC - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: GPC - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: GPC - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: GPC - Cash Flow, 2002-2006 ($ Mn)
- Table 9: GPC - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 10: GPC - in-house Pipeline Products
- Table 11: GPC - Collaboration Products
- Table 12: GPC - Key Competitors
- Table 13: GPC - Key Suppliers
- Table 14: GPC - Key Clients
- Table 15: GPC - SWOT Analysis Summary
- Table 16: GPC - Value Chain Analysis
- Table 17: GPC - Key Employees
- Table 18: GPC - Financial and Operational Overview